Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -332 | -96 | -1,109 | -894 | -172 |
| Depreciation Amortization | 116 | 29 | 134 | N/A | N/A |
| Accounts receivable | -14 | -24 | N/A | 0 | 0 |
| Other Working Capital | 73 | -12 | 35 | 23 | 17 |
| Other Operating Activity | 36 | 34 | 656 | 635 | 0 |
| Operating Cash Flow | $-122 | $-70 | $-285 | $-236 | $-155 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -86 | -61 | -281 | -281 | -206 |
| Investing Cash Flow | $-86 | $-61 | $-281 | $-281 | $-206 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 241 | 136 | 545 | 497 | 396 |
| Financing Cash Flow | $241 | $136 | $545 | $497 | $396 |
| Beginning Cash Position | 1 | 1 | 22 | 22 | 22 |
| End Cash Position | 35 | 7 | 1 | 2 | 57 |
| Net Cash Flow | $33 | $5 | $-21 | $-20 | $35 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122 | -70 | -285 | -236 | -155 |
| Capital Expenditure | -86 | -61 | -281 | -281 | -206 |
| Free Cash Flow | -208 | -131 | -566 | -517 | -361 |